Post-Doctoral Fellowship, Harvard Medical School, 2008

ScD, Harvard School of Public Health, 2007

MPH, Boston University School of Public Health, 2003

Assistant Professor of Psychiatry, Harvard Medical School

Director of Epidemiology, Division of Epidemiology, The Fenway Institute, Fenway Health

Senior Consultant, John Snow Research and Training Institute, Inc.

My Research Team Currently Includes: 3 Post-Doctoral Fellows, 1 Associate Research Scientist, 5 Graduate Students, 2 Epidemiology Project Managers, 1 Data Analyst, 1 Study Therapist, and 8 Research Assistants/Project Coordinators.

In broad terms my research interests are in behavioral medicine, infectious disease and psychiatric epidemiology, and global health. My program of research involves designing and conducting intervention trials in HIV primary and secondary prevention, substance abuse treatment and prevention, and HIV medication adherence with a variety of populations, including sexual minority and other marginalized groups, substance users, adolescents, and individuals in resource limited countries. To date, I have authored or co-authored over 100 peer-reviewed, original research publications on these topics.

I am currently the PI of four NIH funded R grants, two Harvard CFAR grants, a CDC research grant, and a grant funded by the Ragon Institute of MGH, MIT & Harvard working in these areas of research. Furthermore, I am currently a Co-I on four NIH R grants working in these areas of HIV prevention, and am a member of the protocol development team and Co-I for HPTN 063 (PI: Dr. Steven Safren) – a proposal to develop international prevention trials for HIV infected individuals in care settings in Zambia, Thailand, and Brazil. In addition to these three countries above, I am presently conducting global public health research in India, Vietnam, and South Africa, and collaborating on research projects with investigators at U Penn in Ukraine and Russia. Finally, I am the PI of an online study surveying all MSM members of one of the largest social/sexual networking Internet sites in all Latin American countries, Spain, and Portugal.

Current Funded Research Studies For Which I Am PI:

1R34DA031028-01 – Mimiaga (PI) ** 09/01/2010-08/31/2013 ** NIDA - Behavioral Activation and HIV Risk Reduction for MSM with Crystal Meth Abuse. This study (“Project IMPACT”) aims to test a novel treatment for crystal methamphetamine dependence and sexual risk behavior in HIV uninfected MSM, incorporating behavioral activation training therapy with integrated HIV risk reduction counseling.

1R01MH094323-01A1 - Mimiaga/Garofalo (MPI) ** 07/01/2011-06/30/2016 ** NIMH - HIV Prevention Intervention for Young Transgender Women. This study is testing the efficacy of a uniquely targeted HIV risk reduction intervention (“Life Skills”) for sexually experienced young transgender women, ages 16 to 24, in a three-arm randomized controlled trial in two major U.S. cities: Boston and Chicago. Note: Sari L. Reisner, MA (Doctoral Student at HSPH) is a Co-I on this grant.

1R21DA033720-01 – Mimiaga (PI) ** 09/30/2011-08/31/2013 ** NIDA - Information technology for HIV prevention among vulnerable men in India. This study is to develop and pilot test an intervention that will use mobile phone technologies to deliver HIV prevention counseling to reduce sexual risk among male sex workers in Chennai and Mumbai, India. Note: Dr. Beena Thomas is the India/ICMR PI on this grant.

1R21MH095535-01 – Mimiaga/Mitty (MPI) ** 08/09/2011-07/31/2013 ** NIMH - Understanding PrEP Implementation among Club Drug Using MSM. This study has two phases: qualitative interviews (phase 1) and a larger epidemiological assessment (phase 2) among HIV uninfected MSM who report recent club drug use and concurrent sexual risk (in the last 3 months) to gain a better understanding of the facilitators and barriers to PrEP implementation.

200-2012-53307 – Mimiaga/Ojikutu (MPI) ** 10/01/2012-12/31/2014 ** CDC - MAI project to evaluate hierarchical online text messages for Black and Latino MSM. The aims of this study are to understand the differing effects of hierarchical messaging among Black and Latino MSM who are at risk for HIV infection. Hierarchical messaging involves offering multiple prevention methods in succession, leading with the most effective method before introducing other prevention methods that may be less effective. This project will help address this gap in research, and also help advance CDC’s high impact prevention efforts to achieve the goals of the National HIV/AIDS Strategy.

2P30AI060354-06 – Mimiaga (PI) ** 06/01/2010-12/31/2012 ** NIAID (Harvard CFAR) - Improving antiretroviral medication adherence among HIV infected youth. This study is to develop (through extensive qualitative methods) and pilot test in an RCT design a theoretically-driven intervention curriculum (“Positive STEPS”) grounded in the social-cognitive and contextual realities of HIV infected adolescents (aged 13-24) to improve medication adherence.

2P30AI060354-06 - Mimiaga/Mitty (MPI) ** 06/01/2010-12/31/2012 ** NIAID (Harvard CFAR) - Sustaining effects of CM on stimulant use in HIV infected persons. The aims of this study are to develop and implement through an open phase pilot a combined contingency management (CM) and behavioral activation training therapy intervention (“Project REWARD”) aimed at HIV infected individuals who are engaged in HIV care and are currently dependent on stimulants (cocaine, crack or crystal methamphetamine).

EPI 220 – Psych Diagnosis; Clinic and Community Populations (Spring)